TNDM logo

TNDM

Tandem Diabetes Care Inc.

$19.68
+$0.33(+1.71%)
40
Overall
40
Value
36
Tech
44
Quality
How is this score calculated?
Market Cap
$1.11B
Volume
982.54K
52W Range
$9.98 - $29.65
Target Price
$30.20

Company Overview

Mkt Cap$1.11BPrice$19.68
Volume982.54KChange+1.71%
P/E Ratio-11.6Open$19.34
Revenue$940.2MPrev Close$19.35
Net Income$-96.0M52W Range$9.98 - $29.65
Div YieldN/ATarget$30.20
Overall40Value40
Quality44Technical36

No chart data available

About Tandem Diabetes Care Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Medical Devices

Latest News

Goldman Sachs Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)

Goldman Sachs analyst David Roman maintained a Hold rating on Tandem Diabetes Care today and set a price target of $25.00. Roman covers the Healthc...

TipRanks Auto-Generated Intelligence Newsdeska day ago

Goldman Sachs Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)

TipRanks Auto-Generated Intelligence Newsdeska day ago
ABCD
1SymbolPriceChangeVol
2TNDM$19.68+1.7%982.54K
3
4
5
6

Get Tandem Diabetes Care Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.